Playback speed
10 seconds
Scripps' 2019 ASCO Update on Advanced Urothelial Cancer: First-Line Bevacizumab, Maintenance Pembro Effect on PFS, New Data on the Use of Enfortumab Vedotin
By
2019 Scripps MD Anderson's Oncology Update
FEATURING
David Quinn
By
2019 Scripps MD Anderson's Oncology Update
FEATURING
David Quinn
351 views
August 30, 2019
Login to view comments.
Click here to Login